Telomerase-associated apoptotic events by mushroom Ganoderma lucidum on premalignant human urothelial cells by Yuen, JWM et al.
Yuen 1
Telomerase associated apoptotic events by mushroom - Ganoderma lucidum on 
pre-malignant human urothelial cells.
John W.M. Yuen1, Mayur Danny I. Gohel1, and Doris Wai-Ting Au2
Number of manuscript pages: 18
Number of figures: 5
Number of tables: 2
Keywords:
Ganoderma lucidum, Triterpenes, Bladder cancer, Apoptosis, Telomerase, Prevention
1J.W.M. Yuen and M.D.I. Gohel are affiliated with the Dept. of Health Technology & 
Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, 
China.
2D.W.T. Au is affiliated with the Dept. of Biology and Chemistry, City University of 
Hong Kong, Kowloon, Hong Kong Special Administrative Region, China.
Page 1 of 30 PDF proof only
This is the Pre-Published Version.
Yuen 2
ABSTRACT
Relapse of transitional bladder tumors remains a challenge despite advances in 
immunological therapies. The chemopreventive effects of Ganoderma. lucidum on the 
tumorigenic phase of bladder cancer were tested, using a 4-aminobiphenyl (ABP) 
tumorigenic transformable human urothelial cell (HUC-PC) model. Our in vitro data 
clearly show that G. lucidum inhibited the viability and growth of HUC-PC. This 
could be explained by a concomitant induction of apoptosis and inhibition of 
telomerase activity in G. lucidum treated HUC-PC culture. Significant exteriorization 
of phosphatidylserine was detected by Annexin-V on cell surface at 3h upon G. 
lucidum incubation, and the HUC-PC cells subsequently lost the membrane integrity 
for uptake of DNA-specific 7-AAD dye, reaching 100% apoptotic in 48 hours. 
Moreover, the presence of G. lucidum in HUC-PC culture significantly elevated the 
levels of hydrogen peroxide and 8-hydroxy-2’-deoxyguanosine (8-OHdG) production. 
Taken together, physiological doses of G. lucidum promote apoptosis and oxidative 
DNA damage as well as suppress telomerase activity in HUC-PC cultures, which are 
essential to explain its anti-HUC-PC growth properties. The findings of this study 
strongly supports that G. lucidum is a potential source of chemopreventive agents for 
bladder cancer, based on its effectiveness on controlling the pre-malignant urothelial 
cell growth and carcinogen-induced transformation. (199)
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INTRODUCTION
The carcinoma of the urinary bladder is the most common urologic malignancy 
encountered (1,2). The most frequent form (up to 90%) of bladder cancer on clinical 
presentation is urothelial carcinoma, i.e. transitional cell carcinoma (TCC). Risk 
factors for TCC include tobacco exposure, chemicals such as N-nitrosamines and 
aromatic amines (3) and genetic susceptibility (4). Majority of TCC are superficial 
disease (90%) and standard clinical management calls for transurethral resection with 
or without intravesical immunotherapy or chemotherapy (5). The most commonly 
used immunotherapeutic agent - Bacillus Calmette-Guérin (BCG), is based on the 
urothelial internalization to trigger inflammatory response, which ultimately results in 
TNF--induced apoptosis (6). Despite the positive impact (reduction by 20-30% of 
recurrence) and historical applications (30 years) of BCG, recurrence rate of bladder 
cancer remains high with lethal side-effects, as well as with approximately 10-30% of 
recurrent cancers progressing to invasive muscle disease to threaten survival rate (2). 
Therefore, powerful chemopreventive agents are demanded for prevention bladder 
cancer recurrence and progression.
Ganoderma lucidum, called “Red Lingzhi” in China has been used for longevity and 
tonicity in the East for over two thousand years, and because of its perceived health 
benefits, the mushroom are nowadays widely consumed as a supplement for different 
kinds of diseases and health maintenance (7). G. lucidum is commonly used for 
immune boosting and cancer prevention, whereas the evidence of anticancer 
properties comes from experimental studies in vitro and animals to humans’ in vivo
(8). Triterpenes contain skeletons of lanostane and are responsible for the bitter taste 
of G. lucidum, exerting cytotoxic-based carcinostatic activities (9,10). Cytoxicity and 
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growth inhibition on various cancer cells have been well documented, and most of 
them are based on controlling the cell cycle and signaling pathways (11-13). 
Apoptosis has also been demonstrated by G. lucidum in malignant cell lines, such as
leukemia (14-17), and skin (18). Recently, it was reported that G. lucidum inhibits the 
growth of a “chemically tumorigenic transformable” human urothelial cell line (HUC-
PC) (19). However, the toxic mechanisms of G. lucidum on urothelial cells remain 
virtually unknown. The HUC-PC cell line is a clonal line derived from the simian 
virus 40 (SV40) - immortalized urothelial cell line “SV-HUC” cells (20), thus 
providing a relevant model, akin to the intravesical contact exposure of carcinogens 
and candidate therapeutic agents, for understanding the cause-and-effects between 
carcinogenesis and chemoprevention.
Unlimited replicative potential is an essential element for carcinogenesis. The enzyme 
telomerase plays a vital role controlling cell proliferation (21,22), and telomerase 
expression is found in over 85% human cancers, including 95% of all advanced 
malignancies (23). Up-regulation of telomerase can be detected in transformed 
bladder cancer cells (24-26), voided urine (27) and bladder-wash specimens (28) of 
most patients with urothelial cancer. Telomerase has been proposed as a urine-based 
marker for bladder cancer with 70-85% sensitivity and 80-95% specificity (29). 
Emerging evidences show the protective effects of telomerase on cell growth and 
survival (30). In this report concentrated extract of G. lucidum (GLE) at physiological 
doses were found to reduce viability and growth of HUC-PC cells, which could be 
explained by a concomitant suppression of telomerase activity and increase of 
apoptosis under oxidative stress (elevated hydrogen peroxide (H2O2) and oxidative 
DNA damage). 
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MATERIALS AND METHODS
Preparation of concentrated extract from G. lucidum
A proprietary extract composed of G. lucidum fruiting bodies and cracked spores, 
branded ReishiMax GLpTM, was purchased from Pharmanex Inc. (Hong Kong, China). 
The active ingredients of the product was standardized as 13.5% polysaccharides (-
1,3-glucans) and 6% triterpenes (ganoderic acids and other), which is the highest level 
of extractable activities, whereas the remaining 80% composed of nucleosides, fatty 
acids, and amino acids, according to the manufacturer’s technical bulletin. The 
powdered extract was sonicated with 95% ethanol for 30 minutes, and the supernatant 
was further extracted by successive sonication using absolute ethanol (19). The water-
insoluble brown powder, i.e. GLE was retrieved from the filtrate (through 0.45 µm 
polypropylene filter) under reduced pressure.
Cell culture
SV-HUC-PC cell line originates from Department of Human Oncology, University of 
Wisconsin Medical School, gifted by Dr. Rao from the University of California, Los 
Angeles. The cell line was cultured in F12 Ham enriched Dulbecco’s Modified 
Eagle’s Medium (Sigma, St. Louis, MO) with 1% penicillin and streptomycin (10,000 
µg/ml penicillin, 10 mg/ml streptomycin) and 10% Fetal Bovine Serum (GIBCO BRL 
Island, New York, U.S.A.). Logarithmically growing cells were harvested and seeded 
at concentration of 1 x 106 cells per 100-mm culture dish for assays. Cultures were 
maintained at 37oC in a water-saturated atmosphere containing 5% CO2. For assays, 
various concentrations (0, 40, 80 and 100 µM) of GLE (in assay media containing at 
most 0.01% absolute ethanol) were inhibited with HUC-PC cells, in the presence or 
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absence of 100 µM ABP (Sigma, St. Louis, MO), which dissolved in DMSO (Sigma, 
St. Louis, MO) with final concentration at not more than 0.02% in assay media.
LDH cytotoxicity assay and Cell viability
The cytotoxicity of test substances, i.e. 4-aminobiphenyl (ABP, CAS. No. 92-67-1)
and GLE, were tested on the cell lines by using LDH Cytotoxicity Detection kit 
(TaKaRa Bio Inc., Shiga, Japan), preformed on a 96-well microplate. In addition, no 
interference and cytotoxicity was observed from any test substances and solvent 
concentrations used for assays. Cell viability was assessed by using an automated 
Beckman Coulter Vi-CELLTM XR Cell Viability Analyzer with its reagent pack 
(Miami, FL). Percentage cell growth inhibition (%GI) was calculated using the 
following formulae: 
( Mean control viable cell number - Experimental viable cell number )
%GI = ( Mean control Viable cell number - Initial seeded cell number )
X 100
All cell counting results were verified between the manual and automated methods.
Apoptosis assay
The Beckman Coulter annexin V-FITC /7-AAD kit (Immunotech, France) was used 
to measure apoptosis. Briefly, cells were treated with various assay media and assayed 
periodically (at 1, 2, 3, 4, 5, 6, 8, 12 and 48 hours) during the 48-hour incubation. Cell 
analysis was performed on Beckman Coulter COULTER® EPICS® XLTH (Miami, FL) 
equipped with the Elite software version 5. A minimum of 10,000 events were 
collected and measured at FL1 (525nm) and FL4 (675nm). Cells incubated with 3% 
formaldehyde- containing PBS for 30 minutes on ice was used as positive control. 
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Untreated cells without staining were used as negative control, and those with staining 
were used as background control.
Real Time Quantitative –Telomeric Repeat Amplification Protocol (RTQ-TRAP)
Cells (1-5 x 106) were lysed in 1x CHAPS buffer containing RNase inhibitor, and 
incubated on ice for 30 minutes. The lysate was then centrifuged at 12,000g for 40 
minutes at 4oC, and the supernatant was collected (31). Total protein concentration of 
the cell extract was determined using a Bio-Rad Bradford protein assay kit (Hercules, 
CA). The protein level of each extract was adjusted to 10 ng/µl for telomerase activity 
analysis. The telomeric repeat amplification protocol (TRAP) is a landmark method 
for measuring telomerase activity, and a real-time PCR technique has been 
incorporated to allow rapid and precise quantitation (31). TS and ACX Primers were 
purchased from Molecular Information Laboratory (South Korea). 10X TRAP buffer 
containing 200 mM Tris, 630 mM KCl, 35 mM MgCl2, 10 mM EGTA, 1 mg/ml BSA, 
and 0.05% Tween 20 was prepared and stored at -20oC until use. The total volume of 
the reaction mixture was 25 µl, containing 40X SYBR Green (Invitrogen), 1X 
Fluorescein (Bio-Rad), 10mM dNTP (Promega), 0.25 µl Hot Star Taq polymerase 
(Qiagen), 14.75 µl RNase/DNase free distilled water, 0.1 µg each of TS (5'-
AATCCGTCGAGCAGAGTTAG-3') and ACX (5'-GCGCGG(CTTACC)4-3') primers, 
2 µl 10X TRAP buffer, and 5 µl protein extract. The PCR was performed in a 96-well 
microtiter plate on a MyiQ Single-Color Real-Time PCR Detection System. The 
reaction mixture was first incubated at 25oC for 30 minutes to elongate the TS primer. 
The PCR was started at 95oC for 15 minutes to activate the Hot Star Taq polymerase, 
followed by 30-cycle amplification (95oC for 30 seconds, 60oC for 30 seconds, and 
72oC for 60 seconds). Fluorescence signal generated from SYBR green was collected
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and analyzed with iCycler iQ Detector software (Ver. 3.0a; Bio-Rad), where
measurable threshold intensity (threshold cycle; Ct) was achieved or at maximum 30 
cycles. Relative telomerase activity was calculated using the derived equation 2-Ct (1). 
Extracellular H2O2 assay in culture media
Culture media from each study group was collected after 48-hour incubation, and 
filtered using Centricon YM-10 microconcentrator (Millipore Co., Bedford, MA) with 
10nm pore size for the H2O2 assay. The method was based on the FOX assay as 
published elsewhere (32), with minor modifications. Briefly, 100 µl of sample was 
added to 170 µl of working reagent in a 96 microplate well, mixed and left for 20 
minutes at room temperature, and the absorbance at 590 nm was read against a 
complete media blank, using microplate reader (TECAN, Austria). The H2O2
concentration of each sample was read from a standard curve, with 0, 0.5, 1.0, 2.5 and 
5.0 µM working standards freshly prepared from a 30% H2O2 stock solution (RDH).  
8-OHdG ELISA assay
Oxidative DNA damage was analyzed by measuring free 8-OHdG present in the 
culture media. Very low quantity of 8-OHdG is expected in the culture media. 
Filtered culture media were assayed immediately using the Highly Sensitive 8-OHdG 
Check Kit (Japan Institute for Control of Aging, Shizuoka, Japan). The 
manufacturer’s instructions are strictly followed. Duplicated samples of each study 
group were run in triplicate. The outer most wells of the ELISA plate were not used to 
avoid edge effect, and phosphate buffer was added to the unused wells to maintain the 
uniform temperature within the wells. 
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Statistical Analysis
All experiments were performed in duplicate for reproducibility. Descriptive statistics, 
such as mean and standard error, were used to summarize the results. GraphPad Prism 
(GraphPad software, version 3.0 for windows, U.S.A.) was used to perform Student’s 
t test for statistical comparisons. Pearson’s correlation test was carried out to measure
the relationship between measured parameters. Statistical significance was sought at 
two-tailed P-value  0.05.
RESULTS
Effects on HUC-PC cell growth
Cell growth was enhanced by 16%(±4%) with ABP incubation for 48 hours (Table 1). 
22%(±6%) more of the cell growth was shown on ABP-pretreated cells (24 hours) 
followed by 48 a hour-culture in complete media, as compared with control (Table 2). 
The GLE re-extracted from the capsule powder is water-insoluble. As determined by 
LDH release from cells, no direct cytotoxicity was observed from GLE at 80 µg/ml or 
below after 24 hour-incubation, but 14%(±2%) and 100%(±6%) of the cells were 
killed with 100 µg/ml and 200 µg/ml GLE, respectively. Growth inhibition was 
demonstrated at 100% by 80 µg/ml GLE, as initial cell seeding number (i.e. 1 x 106
cell / 100-mm dish) was maintained after 48 hour-incubation, regardless of the 
presence or absence of ABP (Table 1). Table 1 and 2 also summarize the growth 
inhibitory effects of GLE at different concentrations, with ABP treatments, in a dose-
dependent manner. 
Apoptotic effects of GLE on HUC-PC cells
Page 9 of 30 PDF proof only
Yuen 10
As shown in Figure 1a, cell shrinkage, elongation and blebs formation appeared in 48 
hours for GLE-treated cells. A time-dependent progressive apoptotic effect of GLE on 
the cells is shown in Figure 2a & b. When incubated with 80 µg/ml of GLE, about 
30% of the cells were apoptotic at 3 hours, and gradually progressed to reach 70% at 
8 hours, predominantly Annexin-V positive but 7-AAD negative phenotype. At 12 
hours, the apoptotic cell population was maintained at 70%, however, the phenotype 
became both Annexin-V and 7-AAD positive. The cell culture was continued and 
reached 100% apoptotic with almost 60% Annexin-V + 7-AAD positive phenotype. 
10-20% of control cells were shown apoptotic (data not shown). Similar trend of the 
apoptotic process was also shown on the cells treated simultaneously with GLE and 
ABP, which was in a dose-dependent response (Figure 3).
Inhibitory effects of GLE on HUC-PC telomerase activity
Relative telomerase activity was enhanced significantly (P<0.001) by 33%(±4%) for 
ABP-pretreated cells (Figure 4a). When incubated with GLE, 30% of relative 
telomerase activity of HUC-PC was inhibited significantly (P < 0.001), and 40% was 
inhibited for the ABP-pretreated cells (P<0.001), and this inhibitory effect was in a 
dose-dependent manner (Figure 4a & b). However, the relative telomerase activity of 
the cells was inversely proportional to the growth inhibition exerted by GLE (Fig. 4c).
Oxidative stress in apoptotic HUC-PC cells
In the presence of GLE, there was significant increase of H2O2 (P<0.05) and 8-OHdG 
(P<0.01), by 20% and 22% respectively, in the ABP-cultured media (Fig. 5a). The 8-
OHdG formation induced by GLE was in a clear dose-dependent manner (Fig. 5b). In 
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the absence of ABP, 43% of H2O2 in culture media was significantly increased 
(P<0.05) by TRE, but no increment of 8-OHdG was found (data not shown).
DISCUSSION
Findings of the present study support G. lucidum as a source of chemopreventive 
candidate for urothelial cancer. Apoptosis, as measured by morphological and 
cytometric changes, is evident to be one of the main cause contributing for HUC-PC 
growth inhibition. In the early phase of apoptosis, the cells bind positively with 
annexin V, because of the lost of the asymmetry of cell membrane that causes the 
exteriorization of negatively charged phospholipids - phosphatidylserine (PS) from 
the inner leaflet. As shown in the results, the process induced by GLE progressed to 
late apoptosis, irrespective of the presence or absence of ABP, in dose- and time-
dependent manner such that the cells were continuously losing the cell membrane 
integrity and stained positive with DNA specific viability dye –7-amino-actinomycin 
D (7-AAD). This is the first report that G. lucidum suppress pre-malignant urothelial 
cells by promoting apoptosis. These results are consistent with other reports, that 
complex extract or pure Ganoderma triterpenes induce apoptosis on cancer cell lines, 
including the hematopoietic cell lines (14), the highly metastic 95-D lung cancer cells
(17), the human hepatoma HuH-7 cells (33), and pure triterpene compounds, such as 
ganoderic acid T and X (17,33), reported to be active in causing apoptosis. Over 
hundreds of triterpene molecules have been identified in G. lucidum (8). In fact, many 
commercially available G. lucidum products contain complex mixtures of triterpenes 
and polysaccharides as their active ingredients. We, therefore, accentuate the 
importance of studying a re-extracted fraction of active ingredient rich rather than a 
selected pure compound for apoptotic activity.
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The inhibitory effect of G. lucidum on telomerase activity is also demonstrated in the 
present study. Both the basal and ABP-induced telomerase activities were 
significantly reduced to similar levels, in dose-dependent manner. The GLE-induced 
telomerase inhibition is shown to be directly proportional to the growth inhibitory 
effect after 48 hour-incubation. Inhibition of telomerase has been shown to limit 
human cancer cell growth by disrupting telomere maintenance (34). Human tumor 
cells with shortened telomeres are effectively and rapidly killed after inhibiting the 
telomerase enzyme (35). Interestingly, according to the Fenton’s reaction, H2O2 is 
being dissociated to generate hydroxyl radicals that are able to oxidize C-8 position of 
G bases to form 8-OHdG (36). In the present study, the increment of H2O2
concentration could be a possible mechanism that attacks the telomere repeats
(TTAAGGG) of the telomeres, to generate 8-OHdG (dose-dependent) and accelerate 
telomere shortening, which is unlikely to be compensated when telomerase activity is 
being suppressed.
Although oxidative DNA damage, in particular 8-OHdG is widely accepted to be 
mutagenic that promotes carcinogenesis, it has been also proposed as a therapeutic 
strategy through induction of cell cycle arrests (37-39). It is well-known that G2-M 
transition of the cell cycle is a critical checkpoint to verify genomic instability, by
blocking DNA-damaged cells to enter mitosis (40). Some chemotherapeutic agents 
are genotoxic to the DNA during the synthesis (S) phase of cell cycle to cause the G2-
M arrest (41,42). For G. lucidum, the regulation of G2-M related proteins have been 
uncovered recently to suppress cell growth of prostate cancer (13) and hepatoma (43).
In the study of Lu et al, only 6-10% of the HUC-PC cells undergoing G2-M phase cell 
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cycle arrest were induced by G. lucidum, which was insufficient to explain the 
exhibited growth inhibition (19). A combination of apoptosis and oxidative DNA 
damage associated with telomerase inhibition as demonstrated in this study are useful 
to explain significant growth inhibition by GLE on pre-tumorigenic HUC-PC cells 
and other cancer cells.
The worthiness of using cells in pre-cancerous stage is particularly important for 
chemoprevention. Nothing is better than eliminating the adverse cells before it turns 
malignant, especially looking at bladder carcinoma where rate of recurrences remain 
exceptionally high even after complete transurethral resection. The non-tumorigenic 
but ABP-transformable characteristic of HUC-PC cell line provides an excellent
model for studying the chemoprevention of bladder cancer, since majority of bladder 
cancer are diagnosed as TCC at presentation and residual cells after resection are 
regarded as the key stimulus factor for recurrence. The superficial mucosal urothelial 
lining is targeted for attack by carcinogens. The HUC-PC cell line has been proven to 
be sensitive to ABP for tumorigenic transformation (20). It was demonstrated by 
several investigators that the exposure of ABP and its metabolites to HUC-PC cells
caused changes in proteomic profile (44), alteration of F/G-actin ratio (45), formation 
of DNA adducts (46), and instability of the genome (47). In addition, Hahn and 
associates (26) have shown that direct tumorigenic conversion of normal human 
epithelial cells can be achieved by combining ectopic expression of human telomerase 
catalytic subunit with SV40 large-T oncoprotein. Therefore, the enhancement of 
telomerase activity and cell proliferation demonstrated in the present study, provides 
evidence that the carcinogenic transformation of HUC-PC cells requires telomerase 
activation. 
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Conclusively, data presented in the current study provide mechanistic insight on the 
chemopreventive effects of G. lucidum on pre-cancerous human urothelial cells. 
Growth inhibition induced by GLE is mediated via apoptosis associated with 
suppression of telomerase activity and oxidative DNA damage. Our findings support 
G. lucidum is a source of chemopreventive candidate for bladder cancer. Detailed 
evaluations are essential before positioning it into the category of chemoprevention. 
Last but not the least, studies of immunological events including chemotaxis and 
phagocytes are ongoing to define the efficacy and effectiveness of G. lucidum on pre-
malignant cell clearance.
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Table 1. Total viable cell count and growth inhibition measured after 48 hours 
incubation (n=3) with GLE together with ABP.
Exposure (48 hrs) Mean ± SEM 
ABP (M) GLE (g/ml) Viable cell number (x 106)? %GI 
I 0 0 1.95 ± 0.07 - 
II 0 80 0.97 ± 0.05 104 ± 5?*** 
III 100 0 2.26 ± 0.12 - 
IV 100 40 1.56 ± 0.07 56 ± 5?*** 
V 100 80 1.06 ± 0.06 96 ± 5?*** 
VI 100 100 0.48 ± 0.04 141 ± 3?*** 
? Initial cell seeding concentration at 1 x 106 cells / 100-mm dish.?(I) was used as 
control for calculation. ?(II) was used as control for calculation. *** P<0.001.
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Table 2. Total viable cell count and growth inhibition after 48 hours incubation on 
ABP-pretreated cells (n=3).
Exposure Mean ± SEM (n=3) 
24 hrs # 48 hrs ## 
Viable cell number (x 106)
? %GI 
I Media Media 3.40 ± 0.20 - 
II Media 80 g/ml GLE 2.45 ± 0.05 40 ± 2?*
III ABP Media 4.15 ± 0.22 - 
IV ABP 40 g/ml GLE 2.96 ± 0.23 38 ± 7 ?** 
V ABP 80 g/ml GLE 2.40 ± 0.12 56 ± 4 ?*** 
VI ABP 100 g/ml GLE 0.61 ± 0.04 113 ± 1 ?*** 
? Initial cell seeding concentration at 1 x 106 cells / 100-mm dish. ??Pre-treatment of 
either 100 µM ABP or complete medium. ???Post-treatment for 48 hours. ?(I) was  
used as control for calculation. ?(II) was used as control for calculation. * P<0.05; 
** P<0.01; ***P<0.001.
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Figure 1.  
Photographs of HUC-PC taken after 48-hour culture with (a) complete media; (b) 100 
#M ABP in complete media; (c) 80 #g/ml GLE in complete media; and (d) 100 #M
ABP + 80 #g/ml GLE in complete media. Magnification: 100x 
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Figure 2.  
(a) The progress of apoptosis induced by 80 #g/ml GLE. Annexin-V binds specially 
to phosphatidylserine on the cell surface when the asymmetry of membrane 
phospholipids was lost at early apoptosis. 7-AAD is a DNA specific viability dye 
binds DNA guanine-cytosine base pair when membrane integrity of the cells were lost 
at late apoptosis. (b) Biparametric histogram LOG PMT2 (525nm) vs LOG PMT4 
(675nm) shows the progression of apoptosis at important time points. 
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Figure 3.  
Apoptotic events induced by various concentrations of GLE on SV-HUC-PC treated 
simultaneously with 100 #M of ABP for 48 hours. For all concentrations, almost all 
cells turned into apoptotic, with small dose-dependent effects, after 48-hour 
incubation. >60% of cells treated with 40 #g/ml of GLE were at early stage of 
apoptosis (Annexin-V +ve & 7-AAD –ve phenotype). However, about 60% and 
>60% of the cells were at late apoptosis (Annexin-V & 7-AAD +ve phenotype) when 
treated with 80 #g/ml and 100 #g/ml GLE, respectively. 
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Figure 4.  
(a) Relative telomerase activity was compared, media control vs 80 µg/ml GLE; 
***P<0.001, and 100 µM ABP vs 100 µM ABP + 80 µg/ml GLE; ***P<0.001. (b) 
Showing the relative telomerase activity inhibited by GLE (at 0, 40, 80, 100 µg/ml), 
*** P<0.001, n=2. (c) Relative telomerase activity plotted against cell growth 
inhibition percentage induced by GLE of Reishi (Pearson’s correlation r = -0.99, 
P<0.01). 
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Figure 5. 
H2O2 and 8-OHdG formation in culture media were compared, ABP(100 µM) vs 
ABP(100 µM)+ GLE(80 µg/ml), * P<0.05; ** P<0.01, n=6. (b) The dose-dependent 
trend as shown for the 8-OHdG formation induced by GLE (at 0, 50, 100, 200 µg/ml), 
*** P<0.001, n=6. 
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